TIMP2 and lung carcinoma: In a similar mechanism to endothelial cells, TIMP-2 was shown to prevent the activation tyrosine kinase-type receptors (TKR) on human A549 (lung carcinoma), MCF7 (mammary adenocarcinoma), HT1080 fibrosarcoma and Hs68 dermal fibroblast cells [49].